With 0.17 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.22 million shares. During the session, the Banks – Regional company that operates in wider Financial sector, reached to the highest price of $10.27 whereas the lowest price it dropped to was $10.02. The 52-week range on NEWT shows that it touched its highest point at $15.49 and its lowest point at $9.12 during that stretch. It currently has a 1-year price target of $15.30. With its current market cap of 268.95 million, NEWT has annualized dividend of $0.76 while the current yield stands at 7.43%. NEWT paid its most recent dividend on 1744675200, while the ex-dividend date for that was 1744675200. Beta for the stock currently stands at 1.34.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NEWT was up-trending over the past week, with a rise of 3.86%, but this was down by -18.23% over a month. Three-month performance dropped to -20.64% while six-month performance fell -22.44%. The stock lost -5.97% in the past year, while it has lost -19.89% so far this year. A look at the trailing 12-month EPS for NEWT yields 1.94 with Next year EPS estimates of 2.35. For the next quarter, that number is 0.35. This implies an EPS growth rate of 12.55% for this year and 6.41% for next year.
Float and Shares Shorts:
At present, 26.29 million NEWT shares are outstanding with a float of 24.45 million shares on hand for trading. On 2025-03-31, short shares totaled 1.49 million, which was 567.00002 higher than short shares on 1740700800. In addition to Mr. Barry Scott Sloane as the firm’s President, Chairman & CEO, Mr. Michael Scott Price serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.36425 of NEWT’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NEWT since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With NEWT analysts setting a high price target of 18.7 and a low target of 13.5, the average target price over the next 12 months is 15.04. Based on these targets, NEWT could surge 82.8% to reach the target high and rise by 31.96% to reach the target low. Reaching the average price target will result in a growth of 47.02% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.97364 being high and $1.84406 being low. For NEWT, this leads to a yearly average estimate of $1.9238. Based on analyst estimates, the high estimate for the next quarter is $0.55 and the low estimate is $0.46. The average estimate for the next quarter is thus $0.51.
